Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_4
1
8%
Ph not_applicable
10
83%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Other(3)

Detailed Status

Completed9
unknown3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 41 (8.3%)
N/A10 (83.3%)

Trials by Status

unknown325%
completed975%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12